Semaglutide works by imitating the natural hormone glucagon-like peptide-1 (GLP-1), which plays a key role in managing blood ...
With India’s semaglutide patent expiring on 20 March, about 50 branded generics are expected to enter the market.
Tuesday, March 17, 2026 The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including GE Aerospace ...
ET Now on MSN
Ozempic patent expiry buzz: Ajanta Pharma, Sun Pharma, Lupin in focus ahead of semaglutide generic launch
Semaglutide is used to treat type 2 diabetes, working by lowering blood sugar, stimulating insulin secretion, and reducing ...
Search behavior keeps evolving, and algorithms follow closely behind. In 2026, ranking success depends less on isolated ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results